United States Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Search entities
Discover all 32,649 supported financial entities for United States financial markets here.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 2562,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "e1c72920-e88d-4c3e-a520-942a31173097",
"title": "Enbridge (ENB) Commits to 600 MW Solar Project in Texas | ENB Stock News",
"description": "Enbridge (ENB) has finalized its decision to invest in the Clear Fork solar project, a substantial 600 MW initiative situated near San Antonio, Texas. This util",
"keywords": "GuruFocus, Article, News, GuruFocus News, ENB",
"snippet": "Enbridge (ENB, Financial) has finalized its decision to invest in the Clear Fork solar project, a substantial 600 MW initiative situated near San Antonio, Texas...",
"url": "https://www.gurufocus.com/news/2992862/enbridge-enb-commits-to-600-mw-solar-project-in-texas-enb-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000007FF.png?20",
"language": "en",
"published_at": "2025-07-22T12:36:16.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ENB",
"name": "Enbridge Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 54.7539,
"sentiment_score": 0.51543,
"highlights": [
{
"highlight": "<em>Enbridge</em> (ENB, Financial) has f[+255 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Enbridge</em> has budgeted $0.9 bill[+107 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+328 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+309 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Enbridge</em> <em>I[+181 characters]",
"sentiment": 0.8834,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Enbridge</em> <em>Inc</em> (ENB) con[+311 characters]",
"sentiment": 0.9042,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Enbridge</em> <em>Inc</em> (ENB) mai[+173 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Enbridge</em> (ENB) Commits to 600 MW Solar Project in Texas | ENB Stock News",
"sentiment": 0.0258,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "6ad96b7f-272f-40c0-8172-b1b91de693f0",
"title": "NioCorp To Accelerate Pre-Construction Activities at its Elk Creek Critical Minerals Project | NB Stock News",
"description": "NioCorp Developments Ltd. (NB) plans to expedite pre-construction tasks at its Elk Creek Critical Minerals Project. The company raised approximately $60",
"keywords": "GuruFocus, Article, News, GuruFocus News, NB",
"snippet": "NioCorp Developments Ltd. (NB, Financial) plans to expedite pre-construction tasks at its Elk Creek Critical Minerals Project.\n\nThe company raised approximately...",
"url": "https://www.gurufocus.com/news/2992690/niocorp-to-accelerate-preconstruction-activities-at-its-elk-creek-critical-minerals-project-nb-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000JH4.png?20",
"language": "en",
"published_at": "2025-07-22T12:15:25.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "NIOBF",
"name": "NioCorp Developments Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Basic Materials",
"match_score": 69.42994,
"sentiment_score": 0.07775,
"highlights": [
{
"highlight": "<em>NioCorp</em> <em>Developments</em> <[+320 characters]",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "<em>NioCorp</em> <em>Developments</em> <[+285 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "b9739b29-cdfa-4f67-ac9a-15c88015c97e",
"title": "Stifel Boosts Pinterest (PINS) Price Target to $46 | PINS Stock News",
"description": "Stifel has raised its price target for Pinterest (PINS) from $40 to $46 while maintaining a Buy rating. This adjustment is part of the firm's outlook for the di",
"keywords": "GuruFocus, Article, News, GuruFocus News, PINS",
"snippet": "Stifel has raised its price target for Pinterest (PINS, Financial) from $40 to $46 while maintaining a Buy rating. This adjustment is part of the firm's outlook...",
"url": "https://www.gurufocus.com/news/2992860/stifel-boosts-pinterest-pins-price-target-to-46-pins-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BLXJ.png?20",
"language": "en",
"published_at": "2025-07-22T12:35:59.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PINS",
"name": "Pinterest, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 49.587532,
"sentiment_score": 0.38685,
"highlights": [
{
"highlight": "Stifel has raised its price target for <[+312 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+251 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pinterest</em> <em>[+302 characters]",
"sentiment": 0.9313,
"highlighted_in": "main_text"
},
{
"highlight": "Adjusted EBITDA grew to $172 million, de[+335 characters]",
"sentiment": 0.807,
"highlighted_in": "main_text"
},
{
"highlight": "Stifel Boosts <em>Pinterest</em> (PINS) Price Target to $46 | PINS Stock News",
"sentiment": 0.3182,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "4a3fa66f-d760-4fe8-af8c-7f9c7086b5cd",
"title": "Stifel Raises Target for Meta Platforms (META) to $845 | META Stock News",
"description": "Stifel has adjusted its price target for Meta Platforms (META), increasing it from $655 to $845 while maintaining a Buy rating. This update is part of the firm'",
"keywords": "GuruFocus, Article, News, GuruFocus News, META",
"snippet": "Stifel has adjusted its price target for Meta Platforms (META, Financial), increasing it from $655 to $845 while maintaining a Buy rating. This update is part o...",
"url": "https://www.gurufocus.com/news/2992773/stifel-raises-target-for-meta-platforms-meta-to-845-meta-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000098V0.png?20",
"language": "en",
"published_at": "2025-07-22T12:20:16.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "META",
"name": "Meta Platforms Inc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 22.68368,
"sentiment_score": 0.145933,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+298 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+261 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+258 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+311 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Meta</em> <em>Platf[+312 characters]",
"sentiment": 0.9628,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Meta</em> <em>Platforms</em> <em>Inc[+172 characters]",
"sentiment": -0.5719,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "45eb8c9b-eb32-48de-920d-3c231aad9562",
"title": "Stifel Raises Alphabet (GOOG) Price Target Amid Positive Q2 Outlook | GOOG Stock News",
"description": "Stifel has increased its price target for Alphabet (GOOG) from $200 to $218, maintaining a Buy rating on the stock as it releases its Q2 earnings preview for th",
"keywords": "GuruFocus, Article, News, GuruFocus News, GOOG",
"snippet": "Stifel has increased its price target for Alphabet (GOOG, Financial) from $200 to $218, maintaining a Buy rating on the stock as it releases its Q2 earnings pre...",
"url": "https://www.gurufocus.com/news/2992758/stifel-raises-alphabet-goog-price-target-amid-positive-q2-outlook-goog-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000007XQ.png?20",
"language": "en",
"published_at": "2025-07-22T12:19:27.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GOOG",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 18.046707,
"sentiment_score": 0.1361,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+283 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+240 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+239 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+50 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GOOGL",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 42.97693,
"sentiment_score": 0.368333,
"highlights": [
{
"highlight": "Stifel has increased its price target fo[+309 characters]",
"sentiment": 0.8608,
"highlighted_in": "main_text"
},
{
"highlight": "Although <em>Alphabet</em> remains a pre[+321 characters]",
"sentiment": -0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+249 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+239 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+50 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Stifel Raises <em>Alphabet</em> (GOOG) Price Target Amid Positive Q2 Outlook | GOOG Stock News",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "c9d2e681-aa7f-4c61-b80f-f1f4fb994caf",
"title": "Seres Therapeutics (MCRB) Announces Transition in Executive Leadership | MCRB Stock News",
"description": "Seres Therapeutics, identified by the ticker MCRB, has revealed significant changes in its executive team. Thomas DesRosier and Marella Thorell are set to assum",
"keywords": "GuruFocus, Article, News, GuruFocus News, MCRB",
"snippet": "Seres Therapeutics, identified by the ticker MCRB, has revealed significant changes in its executive team. Thomas DesRosier and Marella Thorell are set to assum...",
"url": "https://www.gurufocus.com/news/2992858/seres-therapeutics-mcrb-announces-transition-in-executive-leadership-mcrb-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000AXBF.png?20",
"language": "en",
"published_at": "2025-07-22T12:35:48.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MCRB",
"name": "Seres Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 85.54378,
"sentiment_score": 0.12445,
"highlights": [
{
"highlight": "<em>Seres</em> <em>Therapeutics</em>, id[+236 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+299 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+286 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+258 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+69 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Seres</em> <em>Therapeutics</em> (MCRB) Announces Transition in Executive Leadership | MCRB Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "bd8428b0-c2e5-4951-8fd1-bcf50a8f2400",
"title": "Barclays Downgrades Sarepta Therapeutics (SRPT) with Lower Price Target | SRPT Stock News",
"description": "Sarepta Therapeutics (SRPT) received a downgrade from Barclays on July 22, 2025. The analyst behind this decision, Gena Wang, shifted the rating from \"Overweigh",
"keywords": "GuruFocus, Article, News, GuruFocus News, SRPT",
"snippet": "Sarepta Therapeutics (SRPT, Financial) received a downgrade from Barclays on July 22, 2025. The analyst behind this decision, Gena Wang, shifted the rating from...",
"url": "https://www.gurufocus.com/news/2992815/barclays-downgrades-sarepta-therapeutics-srpt-with-lower-price-target-srpt-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AIQ.png?20",
"language": "en",
"published_at": "2025-07-22T12:30:20.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SRPT",
"name": "Sarepta Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 92.253365,
"sentiment_score": 0.087086,
"highlights": [
{
"highlight": "<em>Sarepta</em> <em>Therapeutics</em> ([+286 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Investors and market watchers should not[+202 characters]",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+261 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+71 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Barclays Downgrades <em>Sarepta</em> <em>Therapeutics</em> (SRPT) with Lower Price Target | SRPT Stock News",
"sentiment": -0.296,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "de8562c4-04d1-4847-975b-f448148f5f8c",
"title": "Seres Therapeutics Announces Leadership Transition | MCRB Stock News",
"description": "Seres Therapeutics (MCRB) has appointed Thomas DesRosier and Marella Thorell as co-CEOs, effective July 31, 2025. Outgoing CEO Eric Shaff will remain on",
"keywords": "GuruFocus, Article, News, GuruFocus News, MCRB",
"snippet": "Seres Therapeutics (MCRB, Financial) has appointed Thomas DesRosier and Marella Thorell as co-CEOs, effective July 31, 2025.\n\nOutgoing CEO Eric Shaff will remai...",
"url": "https://www.gurufocus.com/news/2992729/seres-therapeutics-announces-leadership-transition-mcrb-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000AXBF.png?20",
"language": "en",
"published_at": "2025-07-22T12:17:44.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MCRB",
"name": "Seres Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 82.85872,
"sentiment_score": 0.24695,
"highlights": [
{
"highlight": "<em>Seres</em> <em>Therapeutics</em> (MC[+323 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Seres</em> <em>Therapeutics</em> Announces Leadership Transition | MCRB Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "80e938af-7429-4b49-aa50-1966e0fc7515",
"title": "Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer",
"description": "WARREN, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. ( AQST) (”Aquestive” or the ”Company”), a pharmaceutical company advancin",
"keywords": "GuruFocus, Article, News, Marketwired, AQST",
"snippet": "WARREN, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. ( AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing ...",
"url": "https://www.gurufocus.com/news/2992595/aquestive-therapeutics-names-sherry-korczynski-as-chief-commercial-officer",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-22T12:00:07.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "AQST",
"name": "Aquestive Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 84.601036,
"sentiment_score": 0.506375,
"highlights": [
{
"highlight": "., July 22, 2025 (GLOBE NEWSWIRE) -- <em[+352 characters]",
"sentiment": 0.802,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Aquestive</em> <em>Therapeutic[+170 characters]",
"sentiment": 0.802,
"highlighted_in": "main_text"
},
{
"highlight": "PharmFilm® and the Aquestive logo are r[+239 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Aquestive</em> <em>Therapeutics</em> Names Sherry Korczynski as Chief Commercial Officer",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "60244a92-5dec-48bc-b2fa-df602adc7b0b",
"title": "Oneok (OKE) Price Target Adjusted by Analyst Amid Anticipated Growth | OKE Stock News",
"description": "Analyst J.R. Weston from Raymond James has revised the price target for Oneok (OKE) from $115 to $110, while maintaining an Outperform rating on the stock. The",
"keywords": "GuruFocus, Article, News, GuruFocus News, OKE",
"snippet": "Analyst J.R. Weston from Raymond James has revised the price target for Oneok (OKE, Financial) from $115 to $110, while maintaining an Outperform rating on the ...",
"url": "https://www.gurufocus.com/news/2992857/oneok-oke-price-target-adjusted-by-analyst-amid-anticipated-growth-oke-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000BZX.png?20",
"language": "en",
"published_at": "2025-07-22T12:35:41.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "OKE",
"name": "ONEOK, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 57.924736,
"sentiment_score": 0.362775,
"highlights": [
{
"highlight": "Weston from Raymond James has revised th[+295 characters]",
"sentiment": -0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+278 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+328 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+289 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>ONEOK</em> <em>Inc<[+309 characters]",
"sentiment": 0.9217,
"highlighted_in": "main_text"
},
{
"highlight": "<em>ONEOK</em> <em>Inc</em> (OKE) is nea[+202 characters]",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Oneok</em> (OKE) Price Target Adjusted by Analyst Amid Anticipated Growth | OKE Stock News",
"sentiment": 0.3818,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "5fdffbc3-b608-4fd1-8979-99ff3356d87e",
"title": "BioMarin (BMRN) Target Price Adjusted by Morgan Stanley | BMRN Stock News",
"description": "Morgan Stanley has revised its price target for BioMarin (BMRN), reducing it slightly from $97 to $96 while maintaining an Overweight rating. The investment fir",
"keywords": "GuruFocus, Article, News, GuruFocus News, BMRN",
"snippet": "Morgan Stanley has revised its price target for BioMarin (BMRN, Financial), reducing it slightly from $97 to $96 while maintaining an Overweight rating. The inv...",
"url": "https://www.gurufocus.com/news/2992689/biomarin-bmrn-target-price-adjusted-by-morgan-stanley-bmrn-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000006X4.png?20",
"language": "en",
"published_at": "2025-07-22T12:15:19.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "BMRN",
"name": "BioMarin Pharmaceutical Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 67.63021,
"sentiment_score": 0.442717,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+305 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+297 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+264 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+286 characters]",
"sentiment": 0.8316,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Biomarin</em> <em>P[+257 characters]",
"sentiment": 0.9403,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Biomarin</em> <em>Pharmaceutical</em[+205 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "dda18fd5-425f-4aa2-9484-6a792619de39",
"title": "Veritex (VBTX) Price Target Increased by Analyst | VBTX Stock News",
"description": "Analyst Catherine Mealor from Keefe Bruyette has updated her outlook on Veritex (VBTX), raising the price target from $30 to $37. Despite the increase, she main",
"keywords": "GuruFocus, Article, News, GuruFocus News, VBTX",
"snippet": "Analyst Catherine Mealor from Keefe Bruyette has updated her outlook on Veritex (VBTX, Financial), raising the price target from $30 to $37. Despite the increas...",
"url": "https://www.gurufocus.com/news/2992526/veritex-vbtx-price-target-increased-by-analyst-vbtx-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000AQ35.png?20",
"language": "en",
"published_at": "2025-07-22T11:52:18.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "VBTX",
"name": "Veritex Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 64.29408,
"sentiment_score": 0.38486,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+282 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+257 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+297 characters]",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Veritex</em> <em>Ho[+246 characters]",
"sentiment": 0.9001,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "f9a74996-5cd1-41e5-95e8-997a4ea20022",
"title": "CRSP Target Price Adjusted Amid Revised Revenue Forecasts | CRSP Stock News",
"description": "Bank of America has revised its target price for Crispr Therapeutics (CRSP) from $79 to $78, maintaining a Buy rating on the stock. The adjustment comes as the",
"keywords": "GuruFocus, Article, News, GuruFocus News, CRSP",
"snippet": "Bank of America has revised its target price for Crispr Therapeutics (CRSP, Financial) from $79 to $78, maintaining a Buy rating on the stock. The adjustment co...",
"url": "https://www.gurufocus.com/news/2992507/crsp-target-price-adjusted-amid-revised-revenue-forecasts-crsp-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000B5JW.png?20",
"language": "en",
"published_at": "2025-07-22T11:49:05.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "0VRQ.L",
"name": "CRISPR Therapeutics AG",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 66.53668,
"sentiment_score": 0.08476,
"highlights": [
{
"highlight": "Bank of America has revised its target p[+299 characters]",
"sentiment": -0.0609,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+300 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+287 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+259 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+69 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CRSP",
"name": "CRISPR Therapeutics AG",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 66.536026,
"sentiment_score": 0.08476,
"highlights": [
{
"highlight": "Bank of America has revised its target p[+299 characters]",
"sentiment": -0.0609,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+300 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+287 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+259 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+69 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "4f1c7b5b-7745-44fe-9d74-3f740b6770bf",
"title": "GPC Exceeds Revenue Expectations with Strong Q2 Performance | GPC Stock News",
"description": "Genuine Parts Company (GPC) reported a solid financial performance for the second quarter, with revenue reaching $6.16 billion, surpassing the anticipated $6.1",
"keywords": "GuruFocus, Article, News, GuruFocus News, GPC",
"snippet": "Genuine Parts Company (GPC, Financial) reported a solid financial performance for the second quarter, with revenue reaching $6.16 billion, surpassing the antici...",
"url": "https://www.gurufocus.com/news/2992853/gpc-exceeds-revenue-expectations-with-strong-q2-performance-gpc-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000007UV.png?20",
"language": "en",
"published_at": "2025-07-22T12:35:14.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GPC",
"name": "Genuine Parts Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 28.447132,
"sentiment_score": 0.5842,
"highlights": [
{
"highlight": "<em>Genuine</em> <em>Parts</em> <em>Comp[+291 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Genuine</em> <em>Pa[+203 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "58c9089f-1be7-497d-9d1d-803a142a2166",
"title": "GPC Adjusts Fiscal Year 2025 Revenue and Cash Flow Projections | GPC Stock News",
"description": "Genuine Parts Company (GPC) has revised its fiscal year 2025 guidance, reducing its anticipated revenue growth to 1%-3% from the previously expected 2%-4%. The",
"keywords": "GuruFocus, Article, News, GuruFocus News, GPC",
"snippet": "Genuine Parts Company (GPC, Financial) has revised its fiscal year 2025 guidance, reducing its anticipated revenue growth to 1%-3% from the previously expected ...",
"url": "https://www.gurufocus.com/news/2992816/gpc-adjusts-fiscal-year-2025-revenue-and-cash-flow-projections-gpc-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000007UV.png?20",
"language": "en",
"published_at": "2025-07-22T12:30:21.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GPC",
"name": "Genuine Parts Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 30.263239,
"sentiment_score": 0.327267,
"highlights": [
{
"highlight": "<em>Genuine</em> <em>Parts</em> <em>Comp[+314 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+285 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+264 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+243 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+205 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Genuine</em> <em>Pa[+203 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "b864ba04-c72a-4ef1-81e8-755116d48697",
"title": "Genuine Parts Company Reports Second Quarter 2025 Results and Revises Full-Year Outlook | GPC Stock News",
"description": "Genuine Parts Company (GPC) reported Q2 2025 sales of $6.2 billion, a 3.4% increase year-over-year. \n The company has revised its full-year 2025 revenu",
"keywords": "GuruFocus, Article, News, GuruFocus News, GPC",
"snippet": "Genuine Parts Company (GPC, Financial) reported Q2 2025 sales of $6.2 billion, a 3.4% increase year-over-year.\n\nThe company has revised its full-year 2025 reven...",
"url": "https://www.gurufocus.com/news/2992743/genuine-parts-company-reports-second-quarter-2025-results-and-revises-fullyear-outlook-gpc-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000007UV.png?20",
"language": "en",
"published_at": "2025-07-22T12:18:35.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "0IUX.L",
"name": "Genuine Parts Company",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 117.7603,
"sentiment_score": 0.31325,
"highlights": [
{
"highlight": "<em>Genuine</em> <em>Parts</em> <em>Comp[+295 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "The <em>Genuine</em> <em>Parts</em> <em>[+254 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Despite the top-line growth, <em>Genuine[+331 characters]",
"sentiment": 0.4081,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Genuine</em> <em>Parts</em> <em>Company</em> Reports Second Quarter 2025 Results and Revises Full-Year Outlook | GPC Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "GPC",
"name": "Genuine Parts Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 117.704,
"sentiment_score": 0.31325,
"highlights": [
{
"highlight": "<em>Genuine</em> <em>Parts</em> <em>Comp[+295 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "The <em>Genuine</em> <em>Parts</em> <em>[+254 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Despite the top-line growth, <em>Genuine[+331 characters]",
"sentiment": 0.4081,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Genuine</em> <em>Parts</em> <em>Company</em> Reports Second Quarter 2025 Results and Revises Full-Year Outlook | GPC Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "24c71ad2-8c57-4e26-b307-ce63a3f7ef3f",
"title": "Reserve Bank of India",
"description": "Speeches - Reserve Bank of India",
"keywords": "",
"snippet": "Principal, NIBM, Dr Partha Ray, Members of Faculty, my colleagues from the Reserve Bank of India, and most importantly, our promising future bankers from the PG...",
"url": "https://www.rbi.org.in/scripts/BS_SpeechesView.aspx?id=1515",
"image_url": "https://www.rbi.org.in/images/Twitter_New.png",
"language": "en",
"published_at": "2025-07-22T12:35:00.000000Z",
"source": "rbi.org.in",
"relevance_score": null,
"entities": [
{
"symbol": "SBKFF",
"name": "State Bank of India",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 11.847813,
"sentiment_score": 0.9325,
"highlights": [
{
"highlight": "Over the course of my career, I have bee[+244 characters]",
"sentiment": 0.9325,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "19e5dcf1-fb26-4c09-b45f-69fadc2b94a8",
"title": "Tesla (TSLA) Robotaxi Test in Austin Impresses Analyst | TSLA Stock News",
"description": "Tesla's (TSLA) autonomous ride service was put to the test in Austin, Texas, and the results have left a strong impression. Jose Asumendi, head of global automo",
"keywords": "GuruFocus, Article, News, GuruFocus News, TSLA",
"snippet": "Tesla's (TSLA, Financial) autonomous ride service was put to the test in Austin, Texas, and the results have left a strong impression. Jose Asumendi, head of gl...",
"url": "https://www.gurufocus.com/news/2992852/tesla-tsla-robotaxi-test-in-austin-impresses-analyst-tsla-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00004EP4.png?20",
"language": "en",
"published_at": "2025-07-22T12:34:10.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "TSLA",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 36.976463,
"sentiment_score": 0.317625,
"highlights": [
{
"highlight": "With these developments, <em>Tesla</em> [+321 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+239 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+291 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Tesla</em> <em>Inc<[+264 characters]",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Tesla</em> <em>Inc</em> (TSLA) achie[+239 characters]",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Tesla</em> <em>Inc</em> (TSLA) conti[+156 characters]",
"sentiment": -0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Tesla</em> (TSLA) Robotaxi Test in Austin Impresses Analyst | TSLA Stock News",
"sentiment": 0.4767,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "65df67c4-4a9e-4a58-bfb9-e9e79ef3cc17",
"title": "Raymond James Increases Price Target for HBT Financial to $30 | HBT Stock News",
"description": "Raymond James has upgraded its price target for HBT Financial (HBT), moving it up to $30 from the previous $24, while maintaining an Outperform rating for the s",
"keywords": "GuruFocus, Article, News, GuruFocus News, HBT",
"snippet": "Raymond James has upgraded its price target for HBT Financial (HBT, Financial), moving it up to $30 from the previous $24, while maintaining an Outperform ratin...",
"url": "https://www.gurufocus.com/news/2992851/raymond-james-increases-price-target-for-hbt-financial-to-30-hbt-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-22T12:33:24.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "HBT",
"name": "HBT Financial, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 88.28078,
"sentiment_score": 0.080783,
"highlights": [
{
"highlight": "Raymond James has upgraded its price tar[+172 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+309 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+292 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+271 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+63 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Raymond James Increases Price Target for <em>HBT</em> <em>Financial</em> to $30 | HBT Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "3c314aa7-2562-4f16-b171-6dae5f5f33ea",
"title": "Raymond James Boosts Price Target for Revolve Group (RVLV) | RVLV Stock News",
"description": "Raymond James has increased its price target for Revolve Group (RVLV) from $21 to $25 while maintaining an Outperform rating on the stock. The financial service",
"keywords": "GuruFocus, Article, News, GuruFocus News, RVLV",
"snippet": "Raymond James has increased its price target for Revolve Group (RVLV, Financial) from $21 to $25 while maintaining an Outperform rating on the stock. The financ...",
"url": "https://www.gurufocus.com/news/2992508/raymond-james-boosts-price-target-for-revolve-group-rvlv-rvlv-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BML0.png?20",
"language": "en",
"published_at": "2025-07-22T11:50:08.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "RVLV",
"name": "Revolve Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 60.843224,
"sentiment_score": 0.46405,
"highlights": [
{
"highlight": "Raymond James has increased its price ta[+233 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+293 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+268 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+252 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+324 characters]",
"sentiment": 0.7783,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Revolve</em> <em>Gr[+243 characters]",
"sentiment": 0.9325,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Revolve</em> <em>Group</em> <em>Inc<[+318 characters]",
"sentiment": 0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "Raymond James Boosts Price Target for <em>Revolve</em> Group (RVLV) | RVLV Stock News",
"sentiment": 0.3182,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "472de42b-e84e-4e4a-ac68-1e6c3a4c1176",
"title": "FDA Issues CRL for Replimune's (REPL) Advanced Melanoma Therapy Application | REPL Stock News",
"description": "Replimune (REPL) has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration concerning its Biologics License Application for RP1,",
"keywords": "GuruFocus, Article, News, GuruFocus News, REPL",
"snippet": "Replimune (REPL, Financial) has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration concerning its Biologics License Applicatio...",
"url": "https://www.gurufocus.com/news/2992849/fda-issues-crl-for-replimunes-repl-advanced-melanoma-therapy-application-repl-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BHIM.png?20",
"language": "en",
"published_at": "2025-07-22T12:33:15.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "REPL",
"name": "Replimune Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 51.587616,
"sentiment_score": 0.05766,
"highlights": [
{
"highlight": "<em>Replimune</em> (REPL, Financial) has[+202 characters]",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+295 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+271 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Replimune</em> <em>[+272 characters]",
"sentiment": 0.8834,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Replimune</em> is well-capitalized, [+133 characters]",
"sentiment": -0.5719,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "fa1cb306-cb1e-4fb3-8afc-1997fbb38270",
"title": "Replimune Receives Complete Response Letter from FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma | REPL Stock News",
"description": "Replimune (REPL) receives a Complete Response Letter (CRL) from the FDA for its RP1 application in advanced melanoma. The FDA found the IGNYTE trial ins",
"keywords": "GuruFocus, Article, News, GuruFocus News, REPL",
"snippet": "Replimune (REPL, Financial) receives a Complete Response Letter (CRL) from the FDA for its RP1 application in advanced melanoma.\n\nThe FDA found the IGNYTE trial...",
"url": "https://www.gurufocus.com/news/2992719/replimune-receives-complete-response-letter-from-fda-for-rp1-biologics-license-application-for-the-treatment-of-advanced-melanoma-repl-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BHIM.png?20",
"language": "en",
"published_at": "2025-07-22T12:17:08.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "REPL",
"name": "Replimune Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 52.386635,
"sentiment_score": 0.10572,
"highlights": [
{
"highlight": "<em>Replimune</em> (REPL, Financial) rec[+308 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Replimune</em> <em>Group</em>, <em>I[+154 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Replimune</em> plans to request a Ty[+310 characters]",
"sentiment": -0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "., CEO of <em>Replimune</em>, expressed [+308 characters]",
"sentiment": -0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Replimune</em> Receives Complete Response Letter from FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma | REPL Stock News",
"sentiment": 0.25,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "834c0ad5-410e-408c-9cec-e969f3dbe97f",
"title": "Trimble Inc (TRMB) Expands Distribution Network with APEX Technologies Partnership | TRMB stock news",
"description": "Summary Trimble Inc (TRMB) announced on July 22, 2025, that APEX Technologies, the technology division of McCoy Construction & Forestry, has been named the newe",
"keywords": "GuruFocus, Article, News, GuruFocus News, TRMB",
"snippet": "Summary\n\nTrimble Inc (TRMB, Financial) announced on July 22, 2025, that APEX Technologies, the technology division of McCoy Construction & Forestry, has been na...",
"url": "https://www.gurufocus.com/news/2992667/trimble-inc-trmb-expands-distribution-network-with-apex-technologies-partnership-trmb-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-07-22T12:08:44.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "TRMB",
"name": "Trimble Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 80.98393,
"sentiment_score": 0.19488,
"highlights": [
{
"highlight": "Summary\n\n<em>Trimble</em> <em>Inc</em> ([+188 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Potential challenges in integrating <em>[+257 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "By collaborating with APEX Technologies,[+267 characters]",
"sentiment": -0.25,
"highlighted_in": "main_text"
},
{
"highlight": "FAQ\n\nWhat is the main purpose of the par[+326 characters]",
"sentiment": 0.7399,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Trimble</em> <em>Inc</em> (TRMB) Expands Distribution Network with APEX Technologies Partnership | TRMB stock news",
"sentiment": 0.1027,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "f4b73a2e-3cb7-450f-907f-c29210d99cae",
"title": "Ormat Technologies (ORA) Price Target Raised by JPMorgan Ahead of Q2 Preview | ORA Stock News",
"description": "JPMorgan has adjusted its price target for Ormat Technologies (ORA), increasing it from $75 to $85, while maintaining a Neutral rating on the stock. This change",
"keywords": "GuruFocus, Article, News, GuruFocus News, ORA",
"snippet": "JPMorgan has adjusted its price target for Ormat Technologies (ORA, Financial), increasing it from $75 to $85, while maintaining a Neutral rating on the stock. ...",
"url": "https://www.gurufocus.com/news/2992521/ormat-technologies-ora-price-target-raised-by-jpmorgan-ahead-of-q2-preview-ora-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000C1J.png?20",
"language": "en",
"published_at": "2025-07-22T11:51:44.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ORA",
"name": "Ormat Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Utilities",
"match_score": 86.87669,
"sentiment_score": 0.154467,
"highlights": [
{
"highlight": "JPMorgan has adjusted its price target f[+220 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+299 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+254 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+68 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ormat</em> <em>Technologies</em> (ORA) Price Target Raised by JPMorgan Ahead of Q2 Preview | ORA Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0KDH.L",
"name": "Ormat Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 86.87013,
"sentiment_score": 0.154467,
"highlights": [
{
"highlight": "JPMorgan has adjusted its price target f[+220 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+299 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+254 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+68 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ormat</em> <em>Technologies</em> (ORA) Price Target Raised by JPMorgan Ahead of Q2 Preview | ORA Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "ORA.TA",
"name": "Ormat Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "il",
"type": "equity",
"industry": "Utilities",
"match_score": 86.83087,
"sentiment_score": 0.154467,
"highlights": [
{
"highlight": "JPMorgan has adjusted its price target f[+220 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+299 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+254 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+68 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ormat</em> <em>Technologies</em> (ORA) Price Target Raised by JPMorgan Ahead of Q2 Preview | ORA Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "75e804c1-c3de-45a8-b4bf-8e7811848ec2",
"title": "Hope Bancorp Inc Reports Q2 2025 EPS of $(0.22), Missing Estimates, with Revenue at $117.5 Million",
"description": "Net Loss: Reported a net loss of $27.9 million, or $(0.22) per diluted share, impacted by securities portfolio repositioning and acquisition-related expenses.E",
"keywords": "GuruFocus, Article, News, GuruFocus News, HOPE",
"snippet": "Hope Bancorp Inc (HOPE, Financial) released its 8-K filing on July 22, 2025, detailing its financial performance for the second quarter ended June 30, 2025. The...",
"url": "https://www.gurufocus.com/news/2992847/hope-bancorp-inc-reports-q2-2025-eps-of-022-missing-estimates-with-revenue-at-1175-million",
"image_url": "https://static.gurufocus.com/logos/0C000008J3.png?5",
"language": "en",
"published_at": "2025-07-22T12:32:47.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "HOPE",
"name": "Hope Bancorp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 98.86852,
"sentiment_score": 0.25698,
"highlights": [
{
"highlight": "<em>Hope</em> <em>Bancorp</em> <em>Inc</[+280 characters]",
"sentiment": -0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "Company Overview\n\n<em>Hope</em> <em>Banc[+301 characters]",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "Performance and Challenges\n\nThe second q[+263 characters]",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Achievements\n\nDespite the repo[+238 characters]",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "Income Statement Highlights\n\n<em>Hope</e[+283 characters]",
"sentiment": -0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "Balance Sheet and Cash Flow\n\nAs of June [+269 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Credit Quality and Capital Ratios\n\n<em>H[+311 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Analysis\n\n<em>Hope</em> <em>Bancorp</em>[+252 characters]",
"sentiment": -0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings releas[+78 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hope</em> <em>Bancorp</em> <em>Inc</em> Reports Q2 2025 EPS of $(0.22), Missing Estimates, with Revenue at $117.5 Million",
"sentiment": -0.296,
"highlighted_in": "title"
}
]
},
{
"symbol": "TBNK",
"name": "Territorial Bancorp Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 38.900322,
"sentiment_score": 0.55015,
"highlights": [
{
"highlight": "This loss was primarily due to a securit[+255 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Performance and Challenges\n\nThe second q[+263 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "eaef612b-d9bc-46f0-baad-3a0f114354aa",
"title": "Peoples Bancorp Inc (PEBO) Q2 2025 Earnings: EPS Falls Short at $0.59, Revenue Surpasses Estimates at $126.4 Million",
"description": "Net Income: $21.2 million for Q2 2025, a decrease from $24.3 million in Q1 2025 and $29.0 million in Q2 2024.Earnings Per Share (EPS): Reported at $0.59, falli",
"keywords": "GuruFocus, Article, News, GuruFocus News, PEBO",
"snippet": "On July 22, 2025, Peoples Bancorp Inc (Marietta OH) (PEBO, Financial) released its 8-K filing for the second quarter of 2025. The financial holding company, kno...",
"url": "https://www.gurufocus.com/news/2992840/peoples-bancorp-inc-pebo-q2-2025-earnings-eps-falls-short-at-059-revenue-surpasses-estimates-at-1264-million",
"image_url": "https://static.gurufocus.com/logos/0C00000C6G.png?5",
"language": "en",
"published_at": "2025-07-22T12:31:47.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PEBO",
"name": "Peoples Bancorp Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 107.13024,
"sentiment_score": 0.437586,
"highlights": [
{
"highlight": "On July 22, 2025, <em>Peoples</em> <em>B[+112 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Performance and Challenges\n\n<em>Peoples<[+270 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Achievements\n\nDespite the chal[+334 characters]",
"sentiment": 0.8365,
"highlighted_in": "main_text"
},
{
"highlight": "Metric Q2 2025 Q1 2025 Q2 2024 Net Incom[+338 characters]",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "Overall, while <em>Peoples</em> <em>Banc[+243 characters]",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings releas[+95 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Peoples</em> <em>Bancorp</em> <em>Inc</em> (PEBO) Q2 2025 Earnings: EPS Falls Short at $0.59, Revenue Surpasses Estimates at $126.4 Million",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "e926b480-9226-4fe2-b6d3-f6b97c5f3f66",
"title": "IQVIA Holdings Inc Reports Q2 2025 Revenue of $4.017 Billion, Beating Estimates; Adjusted EPS at $2.81, Surpassing Expectations",
"description": "Revenue: $4,017 million, surpassing the estimated $3,962.97 million and marking a 5.3% increase year-over-year.GAAP Net Income: $266 million, with a GAAP Dilut",
"keywords": "GuruFocus, Article, News, GuruFocus News, IQV",
"snippet": "On July 22, 2025, IQVIA Holdings Inc (IQV, Financial) released its 8-K filing for the second quarter of 2025, showcasing a revenue of $4,017 million, which surp...",
"url": "https://www.gurufocus.com/news/2992827/iqvia-holdings-inc-reports-q2-2025-revenue-of-4017-billion-beating-estimates-adjusted-eps-at-281-surpassing-expectations",
"image_url": "https://static.gurufocus.com/logos/0C00009UD5.png?5",
"language": "en",
"published_at": "2025-07-22T12:30:58.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "IQV",
"name": "IQVIA Holdings Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 104.26965,
"sentiment_score": 0.124225,
"highlights": [
{
"highlight": "On July 22, 2025, <em>IQVIA</em> <em>Hol[+307 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Company Overview\n\n<em>IQVIA</em> <em>Hol[+212 characters]",
"sentiment": 0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings releas[+80 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>IQVIA</em> <em>Holdings</em> <em>Inc</em> Reports Q2 2025 Revenue of $4.017 Billion, Beating Estimates; Adjusted EPS at $2.81, Surpassing Expectations",
"sentiment": -0.4588,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "bd362b65-8405-421d-9760-90e5febef4f0",
"title": "Hope Bancorp Reports 2025 Second Quarter Financial Results | HOPE Stock News",
"description": "Hope Bancorp (HOPE) reports a net loss of $27.9 million for Q2 2025 due to securities portfolio repositioning and other factors. Excluding notable items",
"keywords": "GuruFocus, Article, News, GuruFocus News, HOPE",
"snippet": "Hope Bancorp (HOPE, Financial) reports a net loss of $27.9 million for Q2 2025 due to securities portfolio repositioning and other factors.\n\nExcluding notable i...",
"url": "https://www.gurufocus.com/news/2992788/hope-bancorp-reports-2025-second-quarter-financial-results-hope-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000008J3.png?20",
"language": "en",
"published_at": "2025-07-22T12:21:13.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "HOPE",
"name": "Hope Bancorp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 68.15417,
"sentiment_score": 0.60962,
"highlights": [
{
"highlight": "<em>Hope</em> <em>Bancorp</em> (HOPE, Fi[+244 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hope</em> <em>Bancorp</em>, <em>Inc<[+172 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "Despite these notable items, <em>Hope</e[+293 characters]",
"sentiment": 0.875,
"highlighted_in": "main_text"
},
{
"highlight": "Moreover, the strategic sale of legacy i[+316 characters]",
"sentiment": 0.8934,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hope</em> <em>Bancorp</em> Reports 2025 Second Quarter Financial Results | HOPE Stock News",
"sentiment": 0.5622,
"highlighted_in": "title"
}
]
},
{
"symbol": "TBNK",
"name": "Territorial Bancorp Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 42.050827,
"sentiment_score": 0.589233,
"highlights": [
{
"highlight": "Completion of the <em>Territorial</em> <[+267 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "This loss was attributed to a strategic [+189 characters]",
"sentiment": -0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "The acquisition of <em>Territorial</em> [+283 characters]",
"sentiment": 0.9493,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "0a6a347c-918f-420d-b406-e07a775b2c15",
"title": "MSCI Inc Q2 2025 Earnings: EPS of $3.92 and Revenue of $772.7 Million Surpass Estimates",
"description": "Revenue: $772.7 million, surpassing the estimated $763.51 million, marking a 9.1% increase year-over-year.Diluted EPS: $3.92, exceeding the estimated $3.86, re",
"keywords": "GuruFocus, Article, News, GuruFocus News, MSCI",
"snippet": "On July 22, 2025, MSCI Inc (MSCI, Financial) released its 8-K filing detailing the financial results for the second quarter of 2025. The company reported operat...",
"url": "https://www.gurufocus.com/news/2992679/msci-inc-q2-2025-earnings-eps-of-392-and-revenue-of-7727-million-surpass-estimates",
"image_url": "https://static.gurufocus.com/logos/0C00000VEY.png?5",
"language": "en",
"published_at": "2025-07-22T12:11:06.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "0A8Y.L",
"name": "MSCI Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 64.69083,
"sentiment_score": 0.63825,
"highlights": [
{
"highlight": "On July 22, 2025, <em>MSCI</em> <em>Inc<[+321 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Company Overview\n\n<em>MSCI</em> <em>Inc<[+294 characters]",
"sentiment": 0.802,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, <em>MSCI</em> offers analy[+318 characters]",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "Despite these achievements, <em>MSCI</em[+257 characters]",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "This growth is significant for <em>MSCI<[+226 characters]",
"sentiment": 0.9081,
"highlighted_in": "main_text"
},
{
"highlight": "However, the increase in operating expen[+322 characters]",
"sentiment": 0.9136,
"highlighted_in": "main_text"
},
{
"highlight": "Fernandez, Chairman and CEO of <em>MSCI<[+292 characters]",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "<em>MSCI</em> <em>Inc</em> Q2 2025 Earnings: EPS of $3.92 and Revenue of $772.7 Million Surpass Estimates",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "M1SC34.SA",
"name": "MSCI Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Financial Services",
"match_score": 64.68974,
"sentiment_score": 0.63825,
"highlights": [
{
"highlight": "On July 22, 2025, <em>MSCI</em> <em>Inc<[+321 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Company Overview\n\n<em>MSCI</em> <em>Inc<[+294 characters]",
"sentiment": 0.802,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, <em>MSCI</em> offers analy[+318 characters]",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "Despite these achievements, <em>MSCI</em[+257 characters]",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "This growth is significant for <em>MSCI<[+226 characters]",
"sentiment": 0.9081,
"highlighted_in": "main_text"
},
{
"highlight": "However, the increase in operating expen[+322 characters]",
"sentiment": 0.9136,
"highlighted_in": "main_text"
},
{
"highlight": "Fernandez, Chairman and CEO of <em>MSCI<[+292 characters]",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "<em>MSCI</em> <em>Inc</em> Q2 2025 Earnings: EPS of $3.92 and Revenue of $772.7 Million Surpass Estimates",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "MSCI",
"name": "MSCI Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 39.605034,
"sentiment_score": 0.2745,
"highlights": [
{
"highlight": "On July 22, 2025, <em>MSCI</em> <em>Inc<[+312 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Company Overview\n\n<em>MSCI</em> <em>Inc<[+285 characters]",
"sentiment": 0.802,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings releas[+61 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>MSCI</em> <em>Inc</em> Q2 2025 Earnings: EPS of $3.92 and Revenue of $772.7 Million Surpass Estimates",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "us",
"total_documents": 3945,
"sentiment_avg": 0.28055676867061974
}
]
}
Other details
Entity count
- 32,649